View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Röchling Medical|30 January 2019

Sympfiny® Oral Delivery System for Multiparticulate Drug Formulations

It is often difficult to orally administer the correct amount of medicine to children accurately and safely.

It is often difficult to orally administer the correct amount of medicine to children accurately and safely.

Young patients refuse medicines because many of them are bitter tasting. A leading pharmaceutical company has developed a new way of administering drugs to solve the problem known as multi-particulate drugs.

Multi-particulate drugs are tiny spheres with a protective coating. Measuring between 0.1mm and 0.6mm, the coating neutralises the taste of the active ingredients without impairing their effectiveness. This innovation makes the safe treatment of children considerably easier.

Together with HS Design from Gladstone, NJ/USA, Röchling Medical has developed new drug delivery system Sympfiny® specifically for this new way of administering drugs. It allows for simple and reliable administration and an exact dose. This innovation makes the safe treatment of children considerably easier.

Sympfiny® consists of a container for the drug and an accurately fitting oral syringe for drawing and administering the multi-particulate drug. The oral syringe is connected to the container so that the drug can be precisely dosed, drawn and administered. A plastic part in the syringe allows the dosage to be set safely and transparently. This easy handling means the multi-particulate drugs can be administered as precisely and safely as liquid drugs. With the oral syringe, users can rely on a trusted and proven system that is standard with liquid drugs.

Röchling Medical Division supplies contract manufacturing services relating to plastic processing and precision assembly technology with pharmaceutical, medical, and diagnostics industries.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU